Sotagliflozin As Adjunct Therapy for People with Type 1 to Increase Time in Target Range

A pooled analysis of continuous glucose monitoring (CGM) data obtained from sub-studies of the in Tandem1 and in Tandem2 phase 3 clinical trials was recently presented in poster format. The in Tandem1 and in Tandem2 studies explored the use of oral sotag http://www.diabetesincontrol.com/sotagliflozin-as-adjunct-therapy-for-people-with-type-1/